Jotec Gmbh
Clinical trials sponsored by Jotec Gmbh, explained in plain language.
-
New stent graft aims to tame deadly aortic bulges
Disease control OngoingThis study is testing a special stent graft (a mesh tube) to treat a bulging, weakened area in the main artery of the chest and belly, called a thoracoabdominal aortic aneurysm. The goal is to see if the device is safe and works well to prevent the aneurysm from bursting. About 3…
Sponsor: JOTEC GmbH • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New stent registry aims to improve outcomes for deadly aortic dissection
Disease control OngoingThis study follows 301 people who received the AMDS stent to repair a severe tear in the aorta, the body's main artery. The stent helps keep the damaged vessel open and promotes healing. Researchers are tracking survival and how well the aorta recovers over time.
Sponsor: JOTEC GmbH • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
New stent graft aims to stop deadly aneurysm ruptures
Disease control OngoingThis study is testing a special stent graft (a fabric tube) to treat a bulge in the main artery in the chest and belly, called a thoracoabdominal aortic aneurysm. The goal is to see if the device can prevent death from the aneurysm bursting. The study includes 150 adults aged 18-…
Sponsor: JOTEC GmbH • Aim: Disease control
Last updated May 14, 2026 12:05 UTC